Capturing real-life patient care in psoriatic arthritis and its risks: The challenge of analysing registry data

Arthritis Research and Therapy

Volumn 11, Issue 3, 2009, Pages

  Aletaha, Daniel ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ADALIMUMAB; ETANERCEPT; INFLIXIMAB; METHOTREXATE; TUMOR NECROSIS FACTOR ALPHA ANTIBODY;

ARTICLE; CLINICAL EFFECTIVENESS; CLINICAL PRACTICE; CLINICAL PROTOCOL; COMORBIDITY; DISEASE ACTIVITY; DISEASE REGISTRY; DRUG EFFICACY; DRUG RETENTION; HUMAN; METHODOLOGY; PATIENT CARE; PSORIATIC ARTHRITIS; PUBLICATION; RISK ASSESSMENT; STRATIFICATION; CLINICAL TRIAL; NOTE; REGISTER; RISK; STATISTICS;

ARTHRITIS, PSORIATIC; CLINICAL TRIALS AS TOPIC; HUMANS; PATIENT CARE; REGISTRIES; RISK; STATISTICS AS TOPIC;

EID: 67650730185     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/ar2694     Document Type: Article

References (7)

1. Saad AA Ashcroft DM Watson KD Hyrich KL Noyce PR Symmons DPM Persistence with anti-TNF therapies in patients with psoriatic arthritis: observational study from the British Society of Rheumatology Biologics Register Arthritis Res Ther 2009, 11:R52. 2688203 19356232 10.1186/ar2670
2. Aletaha D Smolen JS Threats to validity of observational studies on disease-modifying antirheumatic drug therapies for rheumatoid arthritis: new aspects after the fall of the pyramid and the rise of new therapeutics Curr Rheumatol Rep 2003, 5:409-412. 10.1007/ s11926-003-0048-y 14609484
3. Pincus T Callahan LF Taking mortality in rheumatoid arthritis seriously - predictive markers, socioeconomic status and comorbidity J Rheumatol 1986, 13:841-845. 3820193
4. del Rincon I Williams K Stern MP Freeman GL Escalante A High incidence of cardiovascular events in a rheumatoid arthritis cohort not explained by traditional cardiac risk factors Arthritis Rheum 2001, 44:2737-2745. 10.1002/1529-0131(200112)44:12<2737::AID-ART4607gt;3.0.CO;2-# 11762933
5. Aletaha D Funovits J Smolen JS The importance of reporting disease activity states in rheumatoid arthritis clinical trials Arthritis Rheum 2008, 58:2622-2631. 10.1002/art.23733 18759299
6. Grigor C Capell H Stirling A McMahon AD Lock P Vallance R Kincaid W Porter D Effect of a treatment strategy of tight control for rheumatoid arthritis (the TICORA study): A single-blind randomised controlled trial Lancet 2004, 364:263-269. 10.1016/S0140-6736(04)16676-2 15262104
7. Aletaha D Smolen JS Effectiveness profiles and dose dependent retention of traditional disease modifying antirheumatic drugs for rheumatoid arthritis. An observational study J Rheumatol 2002, 29:1631-1638. 12180721